Profile Details

Create Project

★★★★★

☆☆☆☆☆

USD 100 /hr

★★★★★

☆☆☆☆☆

Hire Dr. Jan-Philipp C.

Germany

USD 100 /hr

MD–Scientist | Ob/Gyn | Cancer Informatics

Profile Summary

I’m a practicing Obstetrician & Gynecologist at University Hospital Düsseldorf, with a Master of Research in Cancer Informatics from Imperial College London, where I was awarded the Dean’s Prize for academic excellence. I currently hold an Honorary Research Associate position at Imperial, supporting projects at the intersection of clinical medicine, oncology, and digital health. My expertise spans translational cancer research, women’s health, and medical informatics. I have hands-on experience with liquid biopsy technologies, including the isolation and molecular characterization of circulating tumor cells (CTCs) and the analysis of circulating tumor DNA (ctDNA). My work has contributed to advances in minimally invasive cancer diagnostics and personalized treatment strategies. In the digital health space, I’ve developed a clinical information system simulation used in medical education and am currently building patient-facing web applications for individuals with endometriosis. I also have extensive experience with REDCap for clinical study design, data capture, and research project management. This unique combination of clinical insight, research expertise, and digital innovation allows me to support a wide range of healthcare projects—from scientific writing and protocol development to eHealth product design and medical consulting. I’m passionate about translating medical complexity into real-world, evidence-based solutions.

Subject Matter Expertise

• ☆ Biostatistics
• ☆ Information Technology
• ☆ Data Analysis
• ☆ Data Management
• ☆ Statistics
• ☆ Study Design
• ☆ Bioinformatics
• ☆ Information Systems
• ☆ R
• ☆ Clinical Trials
• ☆ Clinical Data Management
• ☆ Women's Health
• ☆ Obstetrics & Gynecology
• ☆ Precision Medicine
• ☆ E-Health & Telemedicine

Services

• Writing
• Research
• Consulting
• Data & AI

Writing Medical Writing

Research Meta-Research, Technology Scouting, Fact Checking, Scientific and Technical Research, Systematic Literature Review

Consulting Healthcare Consulting

Data & AI Statistical Analysis, Image Processing, Image Analysis, Algorithm Design-Non ML, Algorithm Design-ML, Data Visualization, Big Data Analytics, Data Cleaning, Data Processing, Data Insights

Work Experience

Honorary Research Associate

Imperial College London

July 2024 - Present

Medical Doctor

Düsseldorf University Hospital

November 2022 - Present

Education

Master of Research: Cancer Informatics (Department of Surgery and Cancer)

Imperial College London

October 2021 - October 2022

Dr. med. (Doctorate) (Medical Faculty)

Heinrich-Heine-Universität Düsseldorf

January 2018 - October 2022

Medical Doctor (MD) (Medical Faculty)

Heinrich-Heine-Universität Düsseldorf

October 2014 - July 2021

Certifications

• Certification details not provided.

Publications

JOURNAL ARTICLE

Jan-Philipp Cieslik, Annika Sophia Beerbaum, Tanja Fehm, Monika Hampl (2025). Influence of resection distance on vulvar cancer relapse: a retrospective analysis . Archives of Gynecology and Obstetrics.

Jan-Philipp Cieslik, Bianca Behrens, Maggie Banys-Paluchowski, Maximilan Pruss, Melissa Neubacher, Eugen Ruckhäberle, Hans Neubauer, Tanja Fehm, Natalia Krawczyk (2025). Liquid Biopsy in Metastatic Breast Cancer: Path to Personalized Medicine . Oncology Research and Treatment.

Jan-Philipp Cieslik, Maximilian Pruss, Janet Török, Jerome Dobrowolski, Melissa Neubacher, Martina Helbig, Verena Friebe, Lena Häberle, Natalia Krawczyk, Felix Borgmeier, et al. (2025). Hormone and HER2-receptor status in breast cancer: determination using sonographically guided core needle biopsy and correlation with excision specimen—a German single institution diagnostic accuracy study . Archives of Gynecology and Obstetrics.

Jan-Philipp Cieslik, Bianca Behrens, Tanja Fehm, Natalia Krawczyk (2025). Liquid Biopsy beim Mammakarzinom - schneller reagieren, besser behandeln . InFo Hämatologie + Onkologie.

Jan-Philipp Cieslik, Stefan A. Cieslik, Andrés G. Zafra, Christiane Driemel, Monica Sudarsanam, Georg Flügen, Levent Dizdar, Andreas Krieg, Sascha Vaghiri, Hany Ashmawy, et al. (2025). Phenotypic diversity of CTCs and tdEVs in liquid biopsies of tumour-draining veins is linked to poor prognosis in colorectal cancer . Journal of Experimental & Clinical Cancer Research.

George Seed, Nick Beije, Wei Yuan, Claudia Bertan, Jane Goodall, Arian Lundberg, Matthew Tyler, Ines Figueiredo, Rita Pereira, Chloe Baker, et al. (2024). Elucidating acquired PARP inhibitor resistance in advanced prostate cancer . Cancer Cell.

Jan-Philipp Cieslik, Tanja N. Fehm, Christiane Leidinger, André Franken, Bianca Behrens (2024). Die Rolle der Liquid Biopsy beim primären und metastasierten Mammakarzinom . Frauenheilkunde up2date.

Jan-Philipp Cieslik, Maximilian Pruss, Melissa Neubacher, Frederic Dietzel, Natalia Krawczyk, Svjetlana Mohrmann, Eugen Ruckhäberle, Elisabeth C. Sturm-Inwald, Tanja N. Fehm, Bianca Behrens (2024). Retrospective Impact of COVID-19 Pandemic on Primary Breast Cancer Care . Breast Care.

Anna Abramova, Mahdi Rivandi, Liwen Yang, Nadia Stamm, Jan‐Philipp Cieslik, Ellen Honisch, Dieter Niederacher, Tanja Fehm, Hans Neubauer, Andr&#233; Franken (2024). A workflow for the enrichment, the identification, and the isolation of non‐apoptotic single circulating tumor cells for <scp>RNA</scp> sequencing analysis . Cytometry Part A.

Jan-Philipp Cieslik, Tanja Fehm, Volkmar Mueller, Maggie Banys-Paluchowski, Peter A Fasching, Thomas W P Friedl, Andreas Hartkopf, Jens Huober, Christian Loehberg, Brigitte Rack, et al. (2024). Efficacy of Lapatinib in Patients with HER2-Negative Metastatic Breast Cancer and HER2-Positive Circulating Tumor Cells—The DETECT III Clinical Trial . Clinical Chemistry.

Jan-Philipp Cieslik, Matthias W. Beckmann, Frederik A. St&#252;bs, Martin C. Koch, Peter Mallmann, Christian Dannecker, Anna Dietl, Anna Sevnina, Franziska Mergel, Laura Lotz, et al. (2022). Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021) – Part 1 with Recommendations on Epidemiology, Screening, Diagnostics and Therapy . Geburtshilfe und Frauenheilkunde.

Jan-Philipp Cieslik, Tanja Fehm, Frederik A. St&#252;bs, Martin C. Koch, Peter Mallmann, Christian Dannecker, Anna Dietl, Anna Sevnina, Franziska Mergel, Laura Lotz, et al. (2022). Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021) – Part 2 with Recommendations on Psycho-oncology, Rehabilitation, Follow-up, Recurrence, Palliative Therapy and Healthcare Facilities . Geburtshilfe und Frauenheilkunde.

Jan-Philipp Cieslik, Andr&#233; Franken, Bianca Behrens, Florian Reinhardt, Liwen Yang, Mahdi Rivandi, Francesco Marass, Bernadette Jaeger, Natalia Krawczyk, Ellen Honisch, et al. (2021). Multiparametric Circulating Tumor Cell Analysis to Select Targeted Therapies for Breast Cancer Patients . Cancers.

Jan-Philipp Cieslik, Andr&#233; Franken, Bianca Behrens, Florian Reinhardt, Liwen Yang, Mahdi Rivandi, Francesco Marass, Bernadette Jaeger, Natalia Krawczyk, Ellen Honisch, et al. (2021). Multiparametric Circulating Tumor Cell Analysis to Select Targeted Therapies for Breast Cancer Patients . Cancers.

H. Asperger, J.-P. Cieslik, B. Alberter, C. K&#246;stler, B. Polzer, V. M&#252;ller, K. Pantel, S. Riethdorf, A. Koch, A. Hartkopf, et al. (2021). ViBiBa: Virtual BioBanking for the DETECT multicenter trial program - decentralized storage and processing . Translational Oncology.

Hannah Asperger and Nadia Stamm and Berthold Gierke and Michael Pawlak and Ute Hofmann and Ulrich M. Zanger and Annamaria Marton and Robert L. Katona and Andrea Buhala and Csaba Vizler and Jan-Philipp Cieslik and Eugen Ruckhäberle and Dieter Niederacher and Tanja Fehm and Hans Neubauer and Marina Ludescher(2020). Progesterone receptor membrane component 1 regulates lipid homeostasis and drives oncogenic signaling resulting in breast cancer progression . Breast Cancer Research. 22. (1). Springer Science and Business Media {LLC}